Are all EDC effects mediated via steroid hormone receptors?

被引:53
作者
Fisher, JS [1 ]
机构
[1] Univ London, Sch Pharm, London WC1N 1AX, England
关键词
endocrine disruption; phthalate; sulfotransferase; non-receptor mediated; risk assessment;
D O I
10.1016/j.tox.2004.06.035
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Despite the surge of interest in the endocrine disruption field, there is still no globally accepted definition of the term. There is a great political will to test chemicals to determine whether they have endocrine disrupting potential. This is a huge task and the US Environmental Protection Agency has taken the lead by setting up an Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), which with international co-operation, will ultimately deliver a validated testing strategy to detect endocrine disrupting chemicals (EDCs) in humans and wildlife. One of the major developments will be the use of high throughput pre-screening (HTPS) methods that will detect binding to steroid receptor hormones, although many other testing methods will be employed. This paper describes two mechanisms of EDC action that are not mediated via steroid receptors; firstly, the suppression of fetal testosterone synthesis in rodents by in utero exposure to phthalates; and secondly, the ability of several chemicals to interfere with steroid metabolism by inhibiting estrogen sulfotransferases. These examples will be discussed with reference to pertinent human disorders, which have been associated with exposure to EDCs. Issues and questions about how scientists and regulators can deal with these types of chemicals or potential mechanisms in a risk assessment paradigm are raised. (C) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:33 / 41
页数:9
相关论文
共 40 条
  • [1] Quantitative changes in gene expression in fetal rat testes following exposure to Di(n-butyl) phthalate
    Barlow, NJ
    Phillips, SL
    Wallace, DG
    Sar, M
    Gaido, KW
    Foster, PMD
    [J]. TOXICOLOGICAL SCIENCES, 2003, 73 (02) : 431 - 441
  • [2] Estrogenicity of bisphenol A in a human endometrial carcinoma cell line
    Bergeron, RM
    Thompson, TB
    Leonard, LS
    Pluta, L
    Gaido, KW
    [J]. MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1999, 150 (1-2) : 179 - 187
  • [3] Levels of seven urinary phthalate metabolites in a human reference population
    Blount, BC
    Silva, MJ
    Caudill, SP
    Needham, LL
    Pirkle, JL
    Sampson, EJ
    Lucier, GW
    Jackson, RJ
    Brock, JW
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2000, 108 (10) : 979 - 982
  • [4] Environmental pollutants and breast cancer
    Brody, JG
    Rudel, RA
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2003, 111 (08) : 1007 - 1019
  • [5] COLBURN T, 1992, CHEM INDUCED ALTERAT, V12
  • [6] MEDICAL HYPOTHESIS - XENOESTROGENS AS PREVENTABLE CAUSES OF BREAST-CANCER
    DAVIS, DL
    BRADLOW, HL
    WOLFF, M
    WOODRUFF, T
    HOEL, DG
    ANTONCULVER, H
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 1993, 101 (05) : 372 - 377
  • [7] EDSTAC, 1998, Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC) Final Report
  • [8] *EPA, 2002, EPA STAT REG END DIS
  • [9] Environmental anti-androgens and male reproductive health: focus on phthalates and testicular dysgenesis syndrome
    Fisher, JS
    [J]. REPRODUCTION, 2004, 127 (03) : 305 - 315
  • [10] Human 'testicular dysgenesis syndrome': a possible model using in-utero exposure of the rat to dibutyl phthalate
    Fisher, JS
    Macpherson, S
    Marchetti, N
    Sharpe, RM
    [J]. HUMAN REPRODUCTION, 2003, 18 (07) : 1383 - 1394